TEMPEST THERAPEUTICS INC. - COMMON STOCK
0.9856
08-January-25 15:45:00
15 minutes delayed
Stocks
+0.0404
+4.27%
Today's range
0.8500 - 1.0200
ISIN
N/A
Source
NASDAQ
-
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
13 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Tempest Announces Oral and Poster Presentations at the Upcoming 2022 ASCO Annual Meeting
27 Apr 2022 09:01:00 By Nasdaq GlobeNewswire
-
Tempest Announces Private Placement Financing of $15 Million
27 Apr 2022 07:00:02 By Nasdaq GlobeNewswire
-
Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting
08 Apr 2022 12:00:00 By Nasdaq GlobeNewswire
-
Tempest Reports Year End 2021 Financial Results and Provides Business Update
29 Mar 2022 15:00:00 By Nasdaq GlobeNewswire
-
Tempest to Present at the 32nd Annual Oppenheimer Healthcare Conference
10 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2022 15:30:00 By Nasdaq GlobeNewswire
-
Tempest to Present at the 11th Annual SVB Leerink Healthcare Conference
09 Feb 2022 07:00:03 By Nasdaq GlobeNewswire
-
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 Nov 2021 15:05:01 By Nasdaq GlobeNewswire
-
Tempest to Present at Two Upcoming Investor Conferences in November
09 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
01 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
20 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
13 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
Tempest to Present at Upcoming Investor Conferences
09 Sep 2021 15:01:00 By Nasdaq GlobeNewswire